Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 9 recruiting now early-phase tilt small index

Breast Cancer Stage I: early-phase trial registry

9 of 19 indexed Breast Cancer Stage I trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #902 of 28,707 conditions by registered trial count.

19 US clinical trials · 9 currently recruiting · #902 of 28,707 conditions by registered trial count

Breast Cancer Stage I: 19 US clinical trials tracked, 9 recruiting.

Breast Cancer Stage I is the subject of 19 registered US clinical trials on ClinicalTrials.gov, 9 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is Alliance for Clinical Trials in Oncology, running 2 of these trials.

Enrollment posture brief

Registry condition breast-cancer-stage-i

OPEN 9 | RECR 47% | LATE 1 | EARLY 6 | RANK #902 | SPON 2

Nearest open-share peer: Breast Reconstruction (47% recruiting · 19 trials)

Amyotrophic Lateral Sclerosi52.6%Breast Cancer Stage I (this)47%Anesthesia, Local42.1%Alcohol Consumption36.8%Attention Deficit Hyperactiv26.3%
Open-enrollment share among volume-matched conditions near Breast Cancer Stage I

Breast Cancer Stage I lists 9 open slots (47% of 19 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Breast Cancer Stage I on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Breast Cancer Stage I recruits in line with its size-band peers.

    9 of 19 indexed trials (47.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Breast Cancer Stage I trials is spread across many organizations.

    Alliance for Clinical Trials in Oncology accounts for 2 of 19 trials (10.5%). 16 distinct sponsors appear on at least one study for this condition label.

  3. Most Breast Cancer Stage I trials plan to enrol fewer than 100 people.

    Median target enrolment is 86 among the 19 trials that report a genuine target (sentinel values excluded). 12 of those (63.2%) plan for fewer than 100 participants.

  4. Breast Cancer Stage I research is mostly interventional.

    17 interventional and 2 observational studies make up this index (89.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 26Phase 31

Open and recent trials

19 total, page 1 of 1

RECRUITING NA 800 participants

Optimizing Surgical Decisions in Young Adults With Breast Cancer

Weill Medical College of Cornell University

NCT06275126

RECRUITING NA 100 participants

Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial

Fred Hutchinson Cancer Center

NCT06802172

RECRUITING NA 100 participants

Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy

Covenant Health Cancer Center

NCT06006806

RECRUITING Phase 2 90 participants

Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer

UNC Lineberger Comprehensive Cancer Center

NCT06727773

RECRUITING Phase 2 90 participants

Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)

George Washington University

NCT06806930

RECRUITING Phase 2 86 participants

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

University of California, Davis

NCT06268665

RECRUITING Phase 2 45 participants

Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer

University of Virginia

NCT05288777

RECRUITING NA 36 participants

Medical Imaging and Thermal Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI)

Columbia University

NCT05219695

RECRUITING NA 24 participants

A Study of the TheraBionic P1 Device in Breast Cancer

Barbara Ann Karmanos Cancer Institute

NCT07218432

ACTIVE NOT RECRUITING NA 627 participants

Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making

Alliance for Clinical Trials in Oncology

NCT03766009

ACTIVE NOT RECRUITING Phase 3 534 participants

Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection

Alliance for Clinical Trials in Oncology

NCT03927027

ACTIVE NOT RECRUITING Phase 2 119 participants

Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer

H. Lee Moffitt Cancer Center and Research Institute

NCT03384914

ACTIVE NOT RECRUITING NA 102 participants

Taking AIM at Breast Cancer

Dana-Farber Cancer Institute

NCT04720209

ACTIVE NOT RECRUITING NA 34 participants

Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients

Memorial Sloan Kettering Cancer Center

NCT04180579

ACTIVE NOT RECRUITING NA 30 participants

CARE (Chemotherapy Alopecia REduction)

George Washington University

NCT07201389

ACTIVE NOT RECRUITING 23 participants

Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity

Memorial Sloan Kettering Cancer Center

NCT05036252

ACTIVE NOT RECRUITING NA 23 participants

Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors

Case Comprehensive Cancer Center

NCT06336538

COMPLETED 68 participants

Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer

Indiana University School of Medicine

NCT00393341

COMPLETED Phase 2 52 participants

Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors

Ohio State University Comprehensive Cancer Center

NCT02150525

Phase Distribution

PhaseTrial count
Phase 2 6
Phase 3 1

Named interventions

Most-linked intervention names on Breast Cancer Stage I records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Questionnaire Administration Other
2 trials
Questionnaire administration Behavioral
1 trials
Web-based decision aid Other
1 trials
PAXMAN Scalp Cooler Device
1 trials
WOKVAC Vaccine Biological
1 trials
DC1 Vaccine Biological
1 trials
Scalp Cooling by DigniCap Device
1 trials
omega-3 fatty acid Dietary supplement
1 trials

US sites by state

Facility locations filed on Breast Cancer Stage I trials. A trial with sites in several states counts in each.

New York 5 trials
Ohio 3 trials
California 3 trials
North Carolina 2 trials
Massachusetts 2 trials
Indiana 2 trials
Georgia 2 trials
Florida 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Breast Cancer Stage I page

19 registered trials, 9 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Breast Cancer Stage I condition card totals 19 registered trials; most-linked intervention Questionnaire Administration; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.